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During the past year, exciting progress has been made in
elucidating the pathogenesis of Kaposi's sarcoma (KS). It has
been a major focus of research since an aggressive form of
the disease was diagnosed in homosexual men in the USA
(Friedman-Kien et al., 1981), heralding the AIDS epidemic.
Before 1981, three different clinical expressions of the disease
had been recognised. Classical KS is an indolent variant
predominantly affecting elderly men of Mediterranean and
Jewish descent. A more severe form affects children and
young adults in sub-Saharan Africa (endemic KS). Thirdly,
KS constitutes up to 5% of malignancies in immunosup-
pressed allogeneic transplant recipients (Penn, 1983). This
review will focus on the discovery of a putative virus
associated with KS, the role of the human immunodeficiency
virus (HIV) in its pathogenesis and a possible explanation for
the male predominance of the disease.
Epidemiology
The epidemiology of AIDS-KS points to an infectious agent
transmitted independently of HIV. Analysis of 13 000
persons with AIDS reported to the Centres for Disease
Control, Atlanta, GA, USA, up to 1989 revealed that the
incidence of KS in homosexual and bisexual men infected
with HIV is ten times greater than in other seropositive
transmission groups (Beral et al., 1990). The lifetime
incidence in some cohorts of homosexual men with AIDS is
50% (Katz et al., 1994). The initial focus of epidemiological
research concentrated on environmental agents common in
the homosexual community such as amyl nitrate (Mathur
Waugh et al., 1985). However, other studies failed to link KS
with nitrate use (Goedert et al., 1987; Polk et al., 1987).
Geographical clustering of KS cases in the USA has been
demonstrated. The incidence of KS is increased in all AIDS
transmission groups on the west coast and around New
York, the areas of the original epidemic, compared with
other regions (Beral et al., 1990). Moreover, women with
AIDS are four times more likely to develop KS if they
acquired HIV infection from a bisexual partner rather than
from an intravenous drug user (Beral et al., 1990).
A study of the sexual behaviour of 65 homosexual or
bisexual men with AIDS suggested that faeco-oral contact
was likely to be the main route of transmission of a putative
KS infectious agent in this risk group (Beral et al., 1992).
However, blood transmission may also occur as 4% of HIV-
seropositive patients infected by blood transfusion develop
AIDS-KS. The risk of developing KS in haemophiliacs is
lower (1%), implying that blood transmission may be cell
rather than serum related. KS has also been reported in HIV-
negative homosexual men, in whom it follows the indolent
course found in classical KS (Friedman-Kien and Saltzman,
1990). Furthermore, there is evidence that classical KS was
increasing before the AIDS epidemic, with a doubling of
incidence in Sweden over 25 years before 1982 (Dictor and
Attewell, 1988). In the USA there is now a consistent
decrease in the incidence of AIDS-KS (Beral et al., 1990),
with a 4-fold fall among a cohort of homosexual men with
AIDS between 1983 and 1990 (Katz et al., 1994). This could
be related to a genuine drop in prevalence of the agent
causing KS, a reduced rate of transmission because of safe
sex practices or an artefactual reduction caused by under-
reporting of cases. The epidemiological evidence is thus
consistent with an infective agent, transmitted sexually and in
blood, which may have been increasing in prevalence in the
general population before the AIDS epidemic.
Kaposi's sarcoma herpesvirus (KSHV)
Over the last decade, several infective agents have been
proposed as possible causes of KS. However, researchers at
Columbia University recently reported the strongest candi-
date (Chang et al., 1994). They used a novel technique,
representational difference analysis (Lisitsyn et al., 1993), to
detect minor differences between DNA from two sources, in
this case between normal skin and KS lesions from the same
individual. By comparing DNA fragments (representations)
by hybridisation followed by amplification of the differences
between the two specimens, DNA bands were detected that
were unique to the KS tissue. These were cloned and
sequenced and included 330 and 631 bp fragments, known
as KS33OBam and KS63IBam, both of which encoded open
reading frames (orfs). KS33OBam was found to encode an orf
with 51% amino acid homology to a capsid protein of
herpesvirus saimiri (HVS), and 39% homology to the
corresponding protein of Epstein-Barr virus (EBV).
KS63 1Bam encoded an orf with homology to the tegument
proteins of these two viruses. This provided evidence for a
new viral genome related to the gammaherpesviridiae, a class
of lymphotropic herpesviruses. Although these experiments
suggested the presence of a new herpesvirus in AIDS-KS, the
amount of DNA isolated was less than 1% of the expected
herpesvirus genome. This group have further characterised
the putative virus, sequencing a 12 kb genomic fragment.
Three orfs were identified with homologies to the G-protein
receptor and cyclin genes of HVS and an EBV membrane
antigen, and these genes were found to be expressed in KS
tissue (Cesarman et al., 1995a; Cesarman and Knowles,
1995). The putative virus has not yet been shown to be
transmissible, however, there is circumstantial evidence that it
is a novel herpesvirus and is currently designated KSHV
(Kaposi's sarcoma-associated herpesvirus).
Several groups have used the polymerase chain reaction to
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test for the presence of KS33OBam and KS63lBam in KS
tissue. The viral DNA sequences were found in classical KS
specimens as well as AIDS-KS, indicating that the putative
virus may be implicated in the pathogenesis of all forms of
the disease (Su et al., 1995; Huang et al., 1995; Boshoff et al.,
1995; Dupin et al., 1995; Moore and Chang, 1995; Lebbe et
al., 1995; Schalling et al., 1995). The agent was also identified
in African endemic KS (Huang et al., 1995; Lebbe et al.,
1995; Schalling et al., 1995). Furthermore viral sequences
were found in KS lesions from immunosuppressed transplant
recipients (Lebbe et al., 1995; Boshoff et al., 1995) and HIV-
negative homosexual men (Boshoff et al., 1995; Moore and
Chang, 1995) (Table I). Minor nucleic acid sequence
variations have been detected, implying viral polymorphism
(Huang et al., 1995; Moore and Chang, 1995). Northern blot
analysis of AIDS-KS lesions confirmed that in about 20% of
cases the viral orfs were expressed (Huang et al., 1995;
Friedman-Kien, 1995). The viral DNA sequences have also
been found in peripheral blood mononuclear cells from KS
patients, primarily in B-lymphocytes (Ambroziak et al., 1995;
Collandre et al., 1995). Moreover, the sequences have been
identified in normal skin adjacent and distant to both
classical and AIDS-related KS lesions (Dupin et al., 1995;
Lebbe et al., 1995; Moore and Chang, 1995; Friedman-Kien,
1995). In view of the putative mode of transmission, body
fluids and stools from AIDS-KS patients have been analysed.
Semen samples were positive in 3/18 specimens (Ambroziak
et al., 1995; Friedman-Kien, 1995). Stool samples were
negative in 18 cases and sputum rarely positive (1/27)
(Whitby et al., 1995). In addition, non-KS skin lesions from
four HIV-negative immunosuppressed organ transplant
recipients 6-10 years after transplant have been analysed
(Rady et al., 1995). The 33 lesions included actinic keratoses,
basal and squamous cell carcinomas and the viral sequence
was detected in 82% of lesions. These results suggested that
the putative agent may be a widespread latent virus
associated with proliferative skin lesions in immunosup-
pressed patients.
Investigators from Cornell and Columbia Universities
have also examined lymphomas from 42 patients with AIDS
and 151 HIV-negative patients (Cesarman et al., 1995a).
Eight of the lymphomas were body cavity based lymphomas
(BCBL), a rare AIDS associated B-cell lymphoma char-
acterised by pleural, pericardial and peritoneal effusions but
no tumour mass. BCBL expresses an indeterminate
immunophenotype and has clonal immunoglobulin gene
rearrangements (Knowles et al., 1989; Walts et al., 1990;
Green et al., 1995). All eight cases were positive for KSHV;
the other 185 lymphoma specimens were negative. The
sequences were present in high copy number (40-80 per
cell) whereas in KS one copy of the viral genome is estimated
to be present per cell. All eight BCBLs contained clonal EBV,
but the c-myc oncogene was not rearranged as is the case in
Burkitt's lymphoma. The same group has reported 16 further
cases of BCBL, one of which was not AIDS related (Nador
et al., 1995). Three of the AIDS BCBLs were KSHV negative
but had c-myc rearrangements, whereas the 13 KSHV-
positive cases lacked c-myc rearrangements. Clonal EBV
was present in all the AIDS-related BCBLs. These findings
suggest that KSHV infection and c-myc rearrangement may
be alternative mechanisms of induction of malignancy in
EBV-infected cells.
Associations of KSHV with other lymphoproliferative
disorders have also been reported (Table II). Multicentric
Castleman's disease (MCD) is a polyclonal lymphoid
proliferation with vascular hyperplasia causing fever,
splenomegaly and lymphadenopathy. KS occurs more
commonly in patients with MCD (Chen, 1984), particularly
in HIV-positive patients in whom 75% with MCD develop
KS. Biopsies of MCD from 31 patients were tested for
KSHV. The virus was detected in all of 14 AIDS patients,
nine of whom also had KS, and in 7/17 HIV-negative cases,
one of whom had KS (Soulier et al., 1995). KSHV sequences
have been detected in a variety of benign and malignant
Table I Detection of KSHV in Kaposi's sarcoma and control
specimens
Patient group KSHV detected (%)
AIDS-KS 125/128 (98)
Classical KS 49/52 (94)
Endemic KS 24/27 (89)
latrogenic KS 9/9 (100)
HIV-negative homosexual 5/5 (100)
Uninvolved skin, KS patients 21/57 (37)
Control: HIV negativea 3/95 (3)
Pooled data from Chang et al. (1994); Su et al. (1995); Huang et al.
(1995); Boshoffet al. (1995); Dupin et al. (1995); Moore and Chang et
al. (1995); Lebbe et al. (1995); Schalling et al. (1995); Ambroziak et al.
(1995); Colandre et al. (1995); Friedman-Kien et al. (1995); Ekman et
al. (1995). aNormal skin, skin and vascular tumours, surgical biopsies,
opportunistic infections.
Table II Detection of KSHV in lymphoid malignancies, lymphoid
tissue and peripheral blood mononuclear cells
Patient group KSHV detected (%)
BCBL: AIDS 23/26 (89)
BCBL: HIV negative 1/1 (100)
MCD: AIDS 14/14 (100)
MCD: HIV negative 9/19 (47)
Lymphoma/lymphoid tissue: 9/110 (8)
HIV positive
Lymphoma/lymphoid tissue: 18/365 (5)
HIV negative
PBMC: KS 37/70 (53)
PBMC: no KS, HIV positive 11/173 (6)
PBMC: no KS, HIV negative 0/211 (0)
BCBL; body cavity-based lymphoma; MCD; multicentric Castle-
man's disease; PBMC; Peripheral blood mononuclear cells. Pooled
datafrom: Friedman-Kienetal. (1995); Ekmanetal. (1995); Cesarman
et al. (1995a); Whitby et al. (1995); Nador et al. (1995); Karcher and
Alkan (1995); Soulier et al. (1995); Cesarman and Knowles (1995);
Luppi et al. (1995); Ambroziak et al. (1995); Su et al. (1995); Schalling
et al. (1995); Moore and Chang (1995); Chang et al. (1994).
lymphoid disorders in both HIV-positive and -negative
patients, notably in HIV-negative African lymphomas
(Ekman et al., 1995). KSHV is frequently found in the
peripheral blood mononuclear cells (PBMCs) ofpatients with
KS. In a cohort of HIV-positive and AIDS patients, KSHV
was detected in the PBMCs of 24/46 (52%) patients with KS
and 11/143 (8%) of those without KS (Whitby et al., 1995).
The latter group were followed up for a median of 30
months; 6 out of the 11 KSHV-positive patients (55%)
developed KS compared with only 12/132 (9%) of the
KSHV-negative patients. Thus, the presence of KSHV in the
peripheral blood predicts for the development of KS. These
findings support a role for KSHV in KS.
Parallels may be drawn between KSHV and other herpes
viruses. All herpes viruses have the ability to establish latent
infections throughout the lifetime of their host, with periodic
reactivation in order to replicate. Herpes saimiri is the closest
relative of KSHV on the basis of the identified DNA
fragments. It is non-pathogenic in its natural host, the
squirrel monkey, but causes polyclonal T-cell lymphomas and
acute leukaemia in other primates and can transform human
and simian T lymphocytes in vitro (Albrecht et al., 1992).
Herpes saimiri and EBV are gammaherpesviridae that
characteristically infect lymphoblastoid cells in vitro and can
also infect epithelial cells and fibroblasts. EBV immortalises B
cells in vitro and establishes latent infection in human
lymphocytes, where it exists both as circular DNA episomes
and integrated into the host DNA. Similarly, KSHV is found
in B cells and is present as large nuclear episomes (Cesarman
et al., 1995b). Replication of EBV in latently infected B cells
probably uses cellular rather than viral DNA polymerase and
is therefore acyclovir resistant. Immunosuppressed indivi-duals are at risk of reactivation of the viral genome, which
has an aetiological role in the pathogenesis of several
malignancies, including nasopharyngeal carcinoma, Burkitt's
lymphoma and B-cell lymphomas in the immunocompro-
mised, including HIV-positive patients.
In central Africa, EBV antibody titres are raised in 100%
of patients with endemic Burkitt's lymphoma (BL). EBV
alone is not sufficient to induce malignancy and rearrange-
ment of the c-myc oncogene is invariably present. Con-
comitant malaria is thought to produce polyclonal B-cell
proliferation, expanding the population of cells at risk for
transformation, leading to a high incidence of BL. There are
interesting parallels in the epidemiology of EBV and KSHV.
The geographical distribution of endemic BL and endemic
KS are similar. Patients with classical KS have a high
incidence of reticuloendothelial system malignancies, particu-
larly Hodgkin's and non-Hodgkin's lymphomas (Safai et al.,
1980). In addition, 9/17 Sicilian patients were reported to
have had malaria before developing KS (Geddes et al., 1994).
It therefore seems possible that KSHV is an oncogenic
DNA virus with similarities to EBV. The evidence so far
supports the hypothesis that the new herpes virus may
have an aetiological role in all forms of KS, AIDS-
related body cavity lymphoma and possibly in multi-
centric Castleman's disease and skin tumours of
immunosuppressed patients. However, there is controversy
about the significance of these findings. KSHV does not
appear to be a ubiquitous finding and it has been
suggested that the virus may have a permissive rather
than a directly causative role in KS (Gallo, 1995). It is
also possible that KSHV is a 'passenger' virus (Schulz
and Weiss, 1995) that is widely distributed but has
permissive replication in endothelial and lymphoid cells
and in the immunocompromised. KSHV has now been
visualised and been shown to have inducible replication in
cultured BCBL cells indicating latency (Renne et al.,
1996). Further research is underway to determine its
prevalence in the human population.
Origin of Kaposi's sarcoma
All forms of KS have the same characteristic histology
comprising spindle-shaped stromal cells and abnormal
endothelium that lines vascular channels and slit-like spaces
of extravasated red cells. It is not known whether KS is a
polyclonal proliferation or a true malignancy, and the origin
of the spindle cell has been under debate for some years.
Spindle cells contain a normal chromosomal complement and
lack nuclear atypia, which would favour a non-malignant
process. However, lesions from two women with AIDS-KS
were shown to have a clonal origin by an X chromosome
inactivation assay (Rabkin et al., 1995a) and preliminary data
suggest that separate lesions from the same patients are
derived from the same clone, which would favour metastatic
spread from a common source (Rabkin et al., 1995b). In
contrast, immunophenotypic studies of KS biopsies from
endemic, classical and AIDS-KS have revealed heterogeneity
of the spindle cell compartment (Kaaya et al., 1995), which
would support a reactive polyclonal process. Two immuno-
logically distinct but morphologically similar proliferating
spindle cell populations were observed, expressing selective
markers of either haemopoietic (CD45+) or fibroblastic
(TE7+) lineages. When KS cultures were established, the
cells expressed TE7 but neither CD45 nor endothelial
antigens, suggesting selection of cells under tissue culture
conditions. It has been noted that KSHV is lost in KS
cultures after a few passages and two established KS cell
lines, KS-YI (Lunardi-Iskander et al., 1995a) and SLK
(Herndier et al., 1994) are negative for KSHV.
PBMCs from patients with KS have been shown to develop
spindle cell morphology and express endothelial and monocyte
markers when cultured in conditioned media from activated
lymphocytes (Browning et al., 1994). To further define the role
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of KSHV in KS, PCR in situ hybridisation was performed on
KS biopsies (Boshoff et al., 1995b). KSHV signals were
detected in some spindle cells, as well as in endothelial cells
within the lesion but not in neighbouring normal dermal
vessels. The questions of clonality and histogenesis of KS
therefore remain unresolved at present. It is ofinterest that non
Hodgkin's lymphomas arising in immunocompromised pa-
tients may be ofpoly- or oligoclonal origin.
Growth factors
AIDS-KS is more aggressive than any other form of the
disease. This is partly related to the degree of immunosup-
pression in AIDS patients, however KS frequently develops
in patients with CD4 cell counts greater than 200 dl-'.
Recent evidence points to HIV-1 products synergising with
growth factors to promote the growth of AIDS-KS. In
1988, it was found that conditioned media from human
retrovirus infected T cells maintained the growth of AIDS-
KS cells in culture for a year, whereas cytokines and
growth factors did not support long-term survival
(Nakamura et al., 1988). This conditioned media also
supported short-term growth of normal vascular endothe-
lial cells. AIDS-KS cells were also shown to possess
angiogenic activity (Salahuddin et al., 1988). When injected
into chick chorioallantoic membranes AIDS-KS cells caused
rapid and extensive vascularisation, and when inoculated
into nude mice they induced a strong temporary angiogenic
reaction at the site of inoculation.
The tat gene product of HIV is a potent transactivator
which up-regulates viral gene expression by transcriptional
and post-transcriptional enhancement and is necessary for
viral replication. To test the hypothesis that it may also
regulate cellular gene expression leading to the development
of specific diseases associated with HIV infection, transgenic
mice that overexpress tat were generated. Skin changes of
dermal hypercellularity were found in 33/37 male mice but no
female mice, despite equal levels of tat mRNA expression in
the female mice (Vogel et al., 1988). By 12-18 months of
age, 15% of male mice had developed skin tumours
resembling KS. These lesions were multifocal and contained
spindle-shaped cells in the dermis and slit-like spaces with
extravasated blood cells. The growth of AIDS-KS cells in
culture was stimulated 2-fold by conditioned media from
HIV-infected T lymphocytes and this increase was inhibited
by anti-Tat antibodies (Ensoli et al., 1990).
Basic fibroblast growth factor (bFGF) is a potent
angiogenic factor that plays an important role in the growth
of KS. AIDS-KS cells produce high levels of bFGF and its
receptor, which therefore could act as an autocrine growth
promoter in addition to stimulating angiogenesis via
paracrine effects on endothelial cells (Li et al., 1993).
Antisense oligonucleotides to bFGF mRNA inhibit the
growth and angiogenic activity of AIDS-KS cells and the
induction of KS-like lesions by bFGF in nude mice (Ensoli et
al., 1994a). In view of the individual effects of Tat and
bFGF, their interaction was investigated (Ensoli et al.,
1994b). Intradermal injection of bFGF into nude mice
resulted in spindle cell formation and angiogenesis, and
injection of Tat produced similar lesions but to a lesser
extent. However, when bFGF and Tat were injected
simultaneously, macroscopic lesions developed equivalent to
those caused by a ten times higher dose of bFGF alone. This
synergy was even more marked when bFGF was given 2 days
before Tat, but was not demonstrated when Tat was given
first. The synergy was blocked by either anti-Tat or anti-
bFGF antibodies. These experiments suggest that bFGF is
essential for the development of KS-like lesions, and that Tat
enhances bFGF activity.
The effect of Tat in KS is thought to be mediated by
integrin receptors. These are receptors for extracellular matrix
(ECM) proteins, which induce cell adhesion and invasion,
facilitating angiogenesis. The Tat protein has been shown toxInsights into patogenesis of Kaposi's sarcona
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compete with ECM molecules for the integrin receptors 7-A
and :x,#f (Barillari et al.. 1993). Inflammatory cvtokines are
increased in the sera and tissues of HIV-infected homosexual
men. KS lesions in vivo are rich in cvtokines and these.
particularly gamma interferon (Fiorelli et al.. 1995). induce
endothelial cells to express integrin receptors. bFGF also
triggers integrin receptor expression on endothelial and
spindle cells. thereby increasing the availability of binding
sites for Tat. while Tat mimics the effect of ECM molecules.
inducing cell adhesion and invasion. Integrins and bFGF are
present in classical KS lesions. w-hich suggests that Tat may
be in part responsible for the more aggressive clinical course
of KS in AIDS patients.
Human choronic gonadotrophin
The striking male predominance of classical KS was first
noted last century by Kaposi in his original description of the
disease. The male-female ratio was 15:1 but the difference
has reduced in recent years to around 4:1 (Wahman et al..
1991). The gender ratio in African endemic KS is 10:1. except
in children. in whom there is no gender association. Men
develop KS With a greater frequency than women in all HIV
transmission groups (Beral et al.. 1990). Experimentally.
transgenic mice overexpressing tat develop skin lesions
resembling early KS in the male mice but not the female
mice (Vogel et al.. 1988). These findings led to endocrine
studies of KS with therapeutic strategies in mind. However.
neither oestrogen. progesterone nor androgen receptors are
expressed by KS tissues (Ziegler et al.. 1995).
Case reports of complete regression of KS during and
shortly after pregnancy in two women with AIDS (Lunardi-
Iskander et al.. 1995b) led to suggestions that human
chorionic gonadotrophin (hCG) may have a role in the
pathogenesis of KS. Immunohistochemical staining of five
biopsies of AIDS-KS lesions demonstrated the presence of
hCG receptors. w-hich are not expressed by normal human
skin. Nude mice were inoculated with human Kaposi's
sarcoma deri'ved KS-YI cell line and all developed
metastatic KS tumours except four females who became
pregnant. Pregnant mice were then inoculated With KS-Y1:
those inoculated during early pregnancy remained tumour
free whereas those inoculated in late pregnancy generated
small non-metastatic tumours. Mice were inoculated with KS
cells pretreated in *itro with hCG and none developed
tumours. Furthermore. /hCG inhibits the growth of the KS
cell lines KS-YI and SLK. but not smooth muscle or
endothelial cell lines. in a dose-dependent manner. Morpho-
logically. fhCG induced apoptotic death and the levels of the
apoptosis-associated oncogenes c-mvc and c-rel were elevated
(Samaniego et al.. 1995).
The authors hypothesised that the low- rate of KS in
females may be related to the hormonal regulation of
vascular proliferation. Serum levels of fhCG in men and
non-pregnant women are very low (<5 iu l-'). Levels rise
during pregnancy to a maximum at around 10 weeks
gestation (up to 106 iu 1-') and then fall to lower levels in
the second and third trimesters. Luteinising hormone (LH)
binds to the same ovarian receptors as hCG and the fi-
subunits are 85% homologous (Gharib et al.. 1990). In the
non-pregnant female. therefore. it is postulated that high
levels of LH during the luteal phase of the menstrual cycle
may inhibit the neoangiogenesis associated with KS tumour
formation. In homosexual men with AIDS-KS. LH levels are
similar to those in men without KS. although their
testosterone and 17-fi-oestradiol levels are lower (Klauke et
al.. 1995). The promising experimental effects of,hCG have
led to clinical studies. Harrs reported the successful use of
high-dose hCG in the treatment of six patients with extensive
AIDS-KS (Harris. 1995) although we and others have found
hCG at lower doses ineffective and poorly tolerated (Bower et
al.. 1995: von Overbeck et al.. 1995).
Conclusion
During the past ylear there have been several advances in our
understanding of the pathogenesis and growth mechanisms of
KS. A new herpesvirus. KSHV. has been detected in KS
lesions of all types. in various lymphoproliferative disorders.
in skin lesions of post-transplant immunosuppressed indivi-
duals and in some normal individuals. This *irus may
predispose at risk individuals to KS but requires co-factors
for full expression of the disease. These include immunosup-
ression in the case of transplant recipients. endemic KS and
AIDS-KS. The increased severity of AIDS-KS may be due to
HlV-derived Tat protein svnergising with bFGF in the
development of angiogenesis and invasion. The lower
incidence of KS in females mav relate to a protective effect
of hCG or LH. presumably mediated by their effect on
microvasculature. The recent isolation of immortal neoplastic
cell lines (KS-YI and SLK) from patients with KS (Lunardi-
Iskander et al.. 1995a: Herndier et al.. 1994) and grow-th of
KSHV in culture (Renne et al.. 1996) has facilitated the study
of therapeutic strategies in vitro. These advances have
illuminated some of the puzzling epidemiological aspects of
KS and suggest new therapeutic possibilities in the manage-
ment of the disease.
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